Evidence map›Paper›PMID 22233577›Full record

ArticleMolecular pain2012

Neurotrophic factor changes in the rat thick skin following chronic constriction injury of the sciatic nerve.

Jennifer C Peleshok, Alfredo Ribeiro-da-Silva

Open access · goldAbstract read
In one paragraph

Article in Molecular pain, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Schwann cells use TAM receptor-mediated phagocytosis in addition to autophagy to clear myelin in a mouse model of nerve injury.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. Attenuation of the Infiltration of Angiotensin II Expressing CD3Frontiers in molecular neuroscience · 2017
    Article
  10. Article
  11. Article
  12. Neurotrophins and Neuropathic Pain: Role in Pathobiology.Molecules (Basel, Switzerland) · 2015
    Review
  13. Review
  14. Nerve growth factor sensitizes adult sympathetic neurons to the proinflammatory peptide bradykinin.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  15. Pro-neurotrophins, sortilin, and nociception.The European journal of neuroscience · 2014
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jennifer C PeleshokDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada.
Alfredo Ribeiro-da-Silva
McGill University · CA

Funding

ASPE HHS MOP-53278Canadian Institutes of Health Research
6 · The paper itself

Abstract

backgroundCutaneous peripheral neuropathies have been associated with changes of the sensory fiber innervation in the dermis and epidermis. These changes are mediated in part by the increase in local expression of trophic factors. Increase in target tissue nerve growth factor has been implicated in the promotion of peptidergic afferent and sympathetic efferent sprouting following nerve injury. The primary source of nerve growth factor is cells found in the target tissue, namely the skin. Recent evidence regarding the release and extracellular maturation of nerve growth factor indicate that it is produced in its precursor form and matured in the extracellular space. It is our hypothesis that the precursor form of nerve growth factor should be detectable in those cell types producing it. To date, limitations in available immunohistochemical tools have restricted efforts in obtaining an accurate distribution of nerve growth factor in the skin of naïve animals and those with neuropathic pain lesions. It is the objective of this study to delineate the distribution of the precursor form of nerve growth factor to those cell types expressing it, as well as to describe its distribution with respect to those nerve fibers responsive to it.

resultsWe observed a decrease in peptidergic fiber innervation at 1 week after the application of a chronic constriction injury (CCI) to the sciatic nerve, followed by a recovery, correlating with TrkA protein levels. ProNGF expression in CCI animals was significantly higher than in sham-operated controls from 1-4 weeks post-CCI. ProNGF immunoreactivity was increased in mast cells at 1 week post-CCI and, at later time points, in keratinocytes. P75 expression within the dermis and epidermis was significantly higher in CCI-operated animals than in controls and these changes were localized to neuronal and non-neuronal cell populations using specific markers for each.

conclusionsWe describe proNGF expression by non-neuronal cells over time after nerve injury as well as the association of NGF-responsive fibers to proNGF-expressing target tissues. ProNGF expression increases following nerve injury in those cell types previously suggested to express it.

Indexed as

AnimalsBlotting, WesternConstrictionMaleNerve FibersNerve Growth FactorsProtein PrecursorsRatsRats, Sprague-DawleyReceptor, trkASciatic NerveSkinNerve Growth Factorspro-nerve growth factor, ratProtein PrecursorsReceptor, trkA

Identifiers

PMID22233577
PMCPMC3269365
OpenAlexW2064264691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.